Newstral
Article
abc3340.com on 2015-06-17 14:35
Botox maker Allergan adds 'double-chin' drug in $2.1B buy
Related news
- Botox maker Allergan adds 'double-chin' drug with $2.1B dealabc3340.com
- Botox maker Allergan adds 'double-chin' drug in $2.1B buydothaneagle.com
- Botox maker Allergan adds ‘double-chin’ drug in $2.1B buyThe Findlay Courier
- Botox maker Allergan buying Kythera, developer of double chin treatmentLA Times
- AbbVie makes $63B bid for Botox maker Allerganocregister.com
- Carl Icahn buys stake in Botox-maker AllerganThe Salt Lake Tribune
- Pfizer drops merger with Botox maker Allergan after US tax clampdownexpressandstar.com